MDCG issues guidance to help define ‘borderline’ products
Regulatory NewsGareth Macdonald.jpg.jpg.aspx?width=300&height=212&ext=.jpg)
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsEuropeMedical DevicesPharmaceuticalsProduct LifecycleRegulatory NewsGareth MacdonaldBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsEuropeMedical DevicesPharmaceuticalsProduct Lifecycle